Medical Bulletin 08/September/2023 Isra Zaman8 Sept 2023 3:15 PM ISTHere are the top medical news of the day:People with lung conditions face extra risks from climate changePeople living with lung conditions, such as...
People with lung conditions face extra risks from climate change Isra Zaman8 Sept 2023 9:00 AM ISTPeople living with lung conditions, such as asthma and chronic obstructive pulmonary disease (COPD), face even greater risks from climate change,...
People with asthma or COPD face extra risks from climate change Dr. Kamal Kant Kohli4 Sept 2023 7:45 PM ISTPeople living with lung conditions, such as asthma and chronic obstructive pulmonary disease (COPD), face even greater risks from climate change,...
Current diagnostic tools fail to diagnose COPD in African-Americans Jacinthlyn Sylvia18 Aug 2023 10:00 AM ISTA recent study Journal of General Internal Medicine sheds light on a significant disparity in the diagnosis of Chronic Obstructive Pulmonary Disease...
Lupin rolls out Tiotropium Bromide Inhalation Powder for COPD in US Ruchika Sharma17 Aug 2023 12:30 PM ISTMumbai: Pharma major Lupin Limited has announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic ...
People with low levels of vitamin K likely to have poor lung function Dr. Kamal Kant Kohli12 Aug 2023 10:00 AM ISTResearchers have found in a large study that people with low levels of vitamin K have less healthy lungs and are more likely to suffer with...
Inhalation Technique Training Improves Management of Asthma and COPD Jacinthlyn Sylvia7 Aug 2023 9:30 AM ISTInhalation technique training has proven to be a critical factor in managing chronic airway inflammatory conditions such as asthma and chronic...
Lupin arm gets TGA Australia approval for Tiotropium dry powder for inhaler for COPD treatment Ruchika Sharma27 July 2023 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that its wholly-owned subsidiary in Australia, Generic Health Pty Ltd, has received...
Lupin arm unveils Luforbec 100/6 for adult asthma, COPD treatment in Germany Ruchika Sharma22 July 2023 2:30 PM ISTMumbai: Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / ...
Photon-counting CT may evaluate lung structure and function Dr. Kamal Kant Kohli21 July 2023 8:00 PM ISTNew CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT,...
Echocardiography may predict Adverse Outcomes in COPD Patients Dr. Kamal Kant Kohli19 July 2023 8:00 PM ISTCardiovascular diseases often accompany chronic obstructive pulmonary disease (COPD), making their evaluation and management crucial in the overall...
Dupilumab lessens disease severity in COPD patients with type 2 inflammation Dr. Kamal Kant Kohli28 Jun 2023 8:00 PM ISTChronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the...
